Thakur Kiran T, Mateyo Kondwelani, Hachaambwa Lottie, Kayamba Violet, Mallewa Macpherson, Mallewa Jane, Nwazor Ernest O, Lawal Tope, Mallum Chindo B, Atadzhanov Masharip, Boulware David R, Birbeck Gretchen L, Siddiqi Omar K
From the Division of Neuroinfectious Diseases and Neuroimmunology, Department of Neurology (K.T.T.), Johns Hopkins Hospital, Baltimore, MD; the Department of Internal Medicine (K.M., L.H., V.K., M.A., O.K.S.), University of Zambia School of Medicine, Lusaka, Zambia; the Department of Internal Medicine (L.H.), University of Maryland School of Medicine, Baltimore, MD; the Department of Pediatrics and Child Health, College of Medicine (M.M.), and the Department of Internal Medicine (J.M.), Queen Elizabeth Central Hospital, Blantyre, Malawi; the Neurology Unit, Department of Internal Medicine (E.O.N.), Federal Medical Center Owerri, Imo State, Nigeria; the Neurology Unit (T.L.), Department of Internal Medicine, Lagos University Teaching Hospital, Lagos State, Nigeria; the Neurology Unit, Department of Internal Medicine (C.B.M.), Jos University Teaching Hospital, Jos, Plateau State, Nigeria; the Division of Infectious Diseases & International Medicine, Department of Medicine (D.R.B.), University of Minnesota, Minneapolis; Epilepsy Division, Department of Neurology (G.L.B.), University of Rochester, NY; the Chikankata Epilepsy Care Team (G.L.B.), Mazabuka, Zambia; and the Global Neurology Program, Division of Neuroimmunology, Center for Virology and Vaccine Research, Department of Neurology (O.K.S.), Beth Israel Deaconess Medical Center, Boston, MA.
Neurology. 2015 May 12;84(19):1988-90. doi: 10.1212/WNL.0000000000001561.